By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Your Profits Grow Sky High.

Apeiron Biologics gets a EUR 25 million loan from EIB

Apeiron CEO H. Loibner © Apeiron Biologics

The funds are designed to help the company develop new pharmaceutical products for the treatment of cancer, especially rare types affecting children. The financing for Apeiron was made possible by the “European Fund for Strategic Investments” (EFSI).

Apeiron was founded in 2003 by the geneticist Josef Penninger, the scientific director of the Institute for Molecular Biology (IMBA) in Vienna. In May 2017, the European Commission granted market approval for a therapy focusing on immunotherapy of neuroblastoma. The therapy should increase the survival and chances of recovery for the serious cancer neuroblastoma which affects children at an early age. It is a rare cancer, but is responsible for up to 10% of solid tumors in childhood, affecting about 1,200 children in the EU and USA every year.  

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Ukrainian-Austrian Business Forum

    27.4.2021/ 14.00 (CET) , Online Conference

  • Meet us @ Open Vienna - A Thriving Startup Ecosystem

    28.04.2021/ 9.15 am - 1.30 pm (CET), Online Conference

Austria Map

Find the perfect location for your company

Vienna is the perfect place to go for highly qualified talents, and is also superbly geographically positioned in order to be able to provide quick, high-quality services to our customers throughout Europe.

Crayon Austria GmbH

Logo: Crayon Austria GmbH
More testimonials

news from the business location Austria

Medical University of Vienna and Vienna General Hospital: Expertise for lung transplants in cases of COVID-19

In May 2020, a team led by thoracic surgeon Konrad Hoetzenecker of the Department of Surgery of the Medical University of Vienna (MedUni Vienna) and Vienna General Hospital performed a lung transplant on a 44-year-old patient who had been seriously ill with COVID-19, making her the first patient in Europe to receive a lung transplant for this indication.

Rosinger Group

The Rosinger Group is an internationally successful financial group with a long history, which is active in the business areas of “own investments” and “highly specialised consultancy services”.

More news All blog posts